Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

544.01
Delayed Data
As of May 27
 -1.20 / -0.22%
Today’s Change
271.37
Today|||52-Week Range
583.54
+44.88%
Year-to-Date
Sanofi to Sell Its 20.6% Stake in Regeneron, but Keep Their Collaboration Intact
May 26 / MotleyFool.com - Paid Partner Content
Why Sorrento Therapeutics Stock Is on Fire Today
May 18 / MotleyFool.com - Paid Partner Content
Here's Why Editas Could Beat Intellia to a CRISPR Therapy
May 22 / MotleyFool.com - Paid Partner Content
Why Gilead's Remdesivir Might Not Be the Mega-Moneymaker Some Think It Will Be
May 17 / MotleyFool.com - Paid Partner Content
Here's Why Sorrento Therapeutics Dropped 16.6% Today
May 19 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close545.21
Today’s open538.70
Day’s range522.02 - 555.53
Volume5,902,647
Average volume (3 months)1,334,057
Market cap$64.1B
Data as of 4:26pm ET, 05/27/2020

Growth & Valuation

Earnings growth (last year)-14.46%
Earnings growth (this year)+8.73%
Earnings growth (next 5 years)+14.00%
Revenue growth (last year)+17.18%
P/E ratio27.3
Price/Sales5.47
Price/Book5.67

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc-0.01-0.01%
TAKTakeda Pharmaceutica...-0.13-0.67%
----
----
Data as of 4:00pm ET, 05/27/2020

Financials

Next reporting dateJuly 30, 2020
EPS forecast (this quarter)$5.89
Annual revenue (last year)$7.9B
Annual profit (last year)$2.1B
Net profit margin26.91%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Tarrytown, New York

Forecasts